Millie is currently a post-doc at the University of Oxford in the Department of Biochemistry, working on identifying and characterising monoclonal antibodies against Plasmodium falciparum from volunteers vaccinated with the blood stage antigen RH5. She is also using single-cell sequencing to interrogate the antibody response to vaccination.
Millie completed her PhD in the Department of Paediatric Infectious Disease at Imperial College London in 2022, where her work focussed on identifying novel vaccine candidates against Neisseria meningitis using Reverse Vaccinology 2.0. This work involved cloning antibodies from patient samples, before assessing their reactivity and functionality against various N. meningitidis strains. The target antigens of those antibodies with broad reactivity and bactericidal activity were identified, and further investigated as potential vaccine candidates. She has also applied this technique to Streptococcus pneumoniae and Neisseria gonorrhoea.
Millie’s areas of interest include vaccinology, antibodies, bacteria and malaria
Publications
https://orcid.org/my-orcid?orcid=0000-0002-4002-0175
Connect with Millie